Go Pro

Palvella Therapeutics (PVLA) Institutional Ownership

Palvella Therapeutics logo
$155.74 -0.82 (-0.52%)
As of 02:33 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Palvella Therapeutics (NASDAQ:PVLA)

Current
Institutional Ownership
Percentage
40.11%
Number of
Institutional Buyers
(last 12 months)
88
Total
Institutional Inflows
(last 12 months)
$672.13M
Number of
Institutional Sellers
(last 12 months)
27
Total
Institutional Outflows
(last 12 months)
$117.86M
Get PVLA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Palvella Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PVLA Institutional Buying and Selling by Quarter

Palvella Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2026Legal & General Group Plc7,994$1.22M0.0%N/A0.055%
8/14/2026The Manufacturers Life Insurance Company 15,545$2.38M0.0%N/A0.108%
8/12/2026 Northwestern Mutual Wealth Management Co.229$35K0.0%N/A0.002%
8/12/2026 Quantbot Technologies LP462$71K0.0%N/A0.003%
8/11/2026 Blue Owl Capital Holdings LP36,259$5.54M0.8%N/A0.252%
8/11/2026 E Fund Management Co. Ltd.1,602$245K0.0%N/A0.011%
8/11/2026 Lisanti Capital Growth LLC42,975$6.57M1.4%N/A0.298%
8/7/2026 BlackRock Inc.918,357$140.34M0.0%N/A6.373%
8/7/2026 Deutsche Bank AG11,838$1.81M0.0%N/A0.082%
8/6/2026 Bank of New York Mellon Corp30,587$4.67M0.0%N/A0.213%
8/6/2026 State of Wyoming879$134K0.0%N/A0.006%
5/28/2026Avidity Partners Management LP70,000$8.73M1.7%+262.7%0.488%
5/20/2026 Arete Wealth Advisors LLC17,470$2.18M0.1%N/A0.122%
5/19/2026Bank of America Corp DE37,972$4.73M0.0%+25.4%0.265%
5/19/2026 Arete Wealth Advisors LLC17,470$2.18M0.2%N/A0.122%
5/16/2026The Manufacturers Life Insurance Company17,907$2.23M0.0%+688.9%0.125%
5/16/2026First Light Asset Management LLC980,758$122.25M11.0%+38.3%6.838%
5/14/2026Renaissance Technologies LLC17,970$2.24M0.0%-20.2%0.125%
5/14/2026Siren L.L.C.257,485$32.10M0.9%+243.3%1.796%
5/14/2026Sei Investments Co.16,663$2.08M0.0%+42.2%0.116%
5/7/2026WCM Investment Management LLC39,964$4.98M0.0%N/A0.279%
5/7/2026 KBC Group NV224$28K0.0%N/A0.002%
5/7/2026 Swiss National Bank19,400$2.42M0.0%+36.6%0.135%
5/6/2026 Jennison Associates LLC640,611$79.85M0.1%+65.3%4.474%
5/5/2026 Bank of New York Mellon Corp18,041$2.25M0.0%+10.9%0.126%
5/4/2026 Calamos Advisors LLC9,804$1.22M0.0%N/A0.069%
5/4/2026 Emerald Mutual Fund Advisers Trust105,820$13.19M0.6%N/A0.739%
5/4/2026 Emerald Advisers LLC161,500$20.13M0.6%N/A1.129%
5/1/2026 Fifth Third Bancorp19,947$2.49M0.0%N/A0.139%
4/25/2026 Keybank National Association OH1,827$228K0.0%N/A0.013%
4/21/2026 Clio Asset Management LLC90,757$11.31M9.5%-1.0%0.634%
4/16/2026 SG Americas Securities LLC2,472$308K0.0%-8.1%0.017%
2/19/2026Invesco Ltd.54,273$5.68M0.0%+11.6%0.458%
2/18/2026XTX Topco Ltd4,103$429K0.0%N/A0.035%
2/18/2026 Virtus Investment Advisers LLC2,698$282K0.1%N/A0.023%
2/18/2026Wellington Management Group LLP22,403$2.35M0.0%-5.5%0.189%
2/18/2026Superstring Capital Management LP25,469$2.67M1.4%N/A0.215%
2/18/2026Suvretta Capital Management LLC892,400$93.41M1.9%+8.5%7.537%
2/18/2026Perceptive Advisors LLC266,287$27.87M0.5%-32.6%2.249%
2/18/2026Millennium Management LLC3,480$364K0.0%-87.1%0.029%
The cat is out the bag (Ad)

Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel

Watch Porter Stansberry's full investigation into the Final Displacement now
2/18/2026Janus Henderson Group PLC3,600$376K0.0%N/A0.030%
2/18/2026Catalio Capital Management LP10,452$1.09M0.2%-13.0%0.088%
2/18/2026Cinctive Capital Management LP8,707$911K0.0%N/A0.074%
2/18/2026Artia Global Partners LP59,200$6.20M0.9%N/A0.500%
2/18/2026Balyasny Asset Management L.P.108,880$11.40M0.0%-34.6%0.920%
2/18/2026BVF Inc. IL879,009$92.01M3.1%-24.3%7.424%
2/17/2026MPM Bioimpact LLC205,745$21.54M2.5%+205.2%1.738%
2/17/2026First Light Asset Management LLC709,141$74.23M5.7%+30.9%5.989%
2/17/2026Price T Rowe Associates Inc. MD4,090$429K0.0%+11.8%0.035%
2/17/2026California State Teachers Retirement System6,919$724K0.0%+1,512.8%0.058%
2/17/2026 Russell Investments Group Ltd.1,229$129K0.0%+116.4%0.010%
2/17/2026State of Wisconsin Investment Board4,513$472K0.0%N/A0.038%
2/17/2026Summit Partners Public Asset Management LLC389,420$40.76M0.8%+1,016.0%3.289%
2/17/2026Artisan Partners Limited Partnership211,553$22.14M0.0%N/A1.787%
2/17/2026Fred Alger Management LLC150,026$15.70M0.1%-19.7%1.267%
2/17/2026Royal Bank of Canada2,297$240K0.0%-17.4%0.019%
2/16/2026Verition Fund Management LLC11,932$1.25M0.0%N/A0.101%
2/16/2026Mariner LLC11,615$1.22M0.0%-43.9%0.098%
2/16/2026NEXTBio Capital Management LP82,686$8.66M5.1%N/A0.698%
2/16/2026Eventide Asset Management LLC101,748$10.65M0.2%N/A0.859%
2/16/2026Avidity Partners Management LP19,300$2.02M0.6%N/A0.163%
2/16/2026Barclays PLC25,136$2.63M0.0%+157.1%0.212%
2/13/2026Marshall Wace LLP9,484$993K0.0%N/A0.080%
2/13/2026The Manufacturers Life Insurance Company 2,270$238K0.0%N/A0.019%
2/13/2026Rafferty Asset Management LLC15,734$1.65M0.0%N/A0.133%
2/13/2026Siren L.L.C.75,000$7.85M0.2%N/A0.633%
2/13/2026Charles Schwab Investment Management Inc.21,633$2.26M0.0%+3.0%0.183%
2/13/2026 State Street Corp420,462$44.01M0.0%+206.3%3.551%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC47,681$4.99M0.0%N/A0.403%
2/13/2026Wells Fargo & Company MN10,928$1.14M0.0%+48.8%0.092%
2/12/2026Renaissance Technologies LLC22,530$2.36M0.0%-74.9%0.190%
2/12/2026 Federated Hermes Inc.368,038$38.52M0.1%+8.6%3.108%
2/12/2026 New York State Common Retirement Fund17,315$1.81M0.0%+518.4%0.146%
2/12/2026 Alps Advisors Inc.9,716$1.02M0.0%+77.1%0.082%
2/12/2026 Swiss National Bank14,200$1.49M0.0%N/A0.120%
2/12/2026 Nuveen LLC19,576$2.05M0.0%+54.1%0.165%
2/12/2026Group One Trading LLC332$35K0.0%+151.5%0.003%
2/11/2026 Deutsche Bank AG6,594$690K0.0%+8.7%0.056%
2/11/2026Letko Brosseau & Associates Inc.3,500$366K0.0%-32.7%0.030%
2/11/2026 LPL Financial LLC3,448$361K0.0%N/A0.029%
2/11/2026Clearbridge Investments LLC60,628$6.35M0.0%N/A0.512%
2/10/2026Goldman Sachs Group Inc.98,935$10.36M0.0%-58.2%0.836%
2/10/2026Peapack Gladstone Financial Corp3,000$314K0.0%N/A0.025%
2/10/2026 Intech Investment Management LLC3,469$363K0.0%-16.0%0.029%
2/9/2026 Geode Capital Management LLC178,992$18.74M0.0%+6.5%1.512%
2/9/2026Royce & Associates LP30,010$3.14M0.0%-39.4%0.253%
2/9/2026 Blue Owl Capital Holdings LP40,259$4.21M0.3%-57.7%0.340%
2/9/2026 Lisanti Capital Growth LLC41,470$4.34M1.0%N/A0.350%
2/6/2026 Legato Capital Management LLC11,385$1.19M0.1%N/A0.096%
2/6/2026 PSP Research LLC5,084$532K0.5%N/A0.043%
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
2/6/2026 Profund Advisors LLC5,813$608K0.0%N/A0.049%
2/5/2026 Baader Bank Aktiengesellschaft3,131$326K0.0%N/A0.026%
2/2/2026 Chung Wu Investment Group LLC2,600$272K0.2%+1,200.0%0.022%
1/30/2026 Sigma Planning Corp6,500$680K0.0%N/A0.055%
1/30/2026 Jennison Associates LLC387,483$40.56M0.0%+262.4%3.273%
1/30/2026 Certuity LLC3,000$314K0.0%N/A0.025%
1/29/2026 Deltec Asset Management LLC2,400$251K0.0%-80.8%0.020%
1/29/2026UBS Group AG36,505$3.82M0.0%+78.6%0.308%
1/29/2026Vanguard Group Inc.560,616$58.68M0.0%+13.3%4.735%
1/29/2026 China Universal Asset Management Co. Ltd.1,600$167K0.0%N/A0.014%


PVLA Institutional Ownership - Frequently Asked Questions

During the previous two years, 116 institutional investors and hedge funds held shares of Palvella Therapeutics. The most heavily invested institutionals were BlackRock Inc. ($140.34M), First Light Asset Management LLC ($122.25M), Suvretta Capital Management LLC ($93.41M), BVF Inc. IL ($92.01M), Jennison Associates LLC ($79.85M), Vanguard Group Inc. ($58.68M), and State Street Corp ($44.01M).Learn more on Palvella Therapeutics' institutional investors.

40.11% of Palvella Therapeutics' stock is owned by institutional investors. Learn more on PVLA's institutional investor holdings.

Of the 109 institutional investors that purchased Palvella Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: First Light Asset Management LLC ($980.76K), BlackRock Inc. ($918.36K), Suvretta Capital Management LLC ($892.40K), Frazier Life Sciences Management L.P. ($722.40K), BVF Inc. IL ($696.56K), Samsara BioCapital LLC ($679.49K), and Jennison Associates LLC ($533.70K).

Institutional investors have bought a total of 6,500,760 shares in the last 24 months. This purchase volume represents approximately $672.13M in transactions.

Of the 26 institutional investors that sold Palvella Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($311.51K), BVF Inc. IL ($282.24K), Goldman Sachs Group Inc. ($137.70K), Perceptive Advisors LLC ($128.81K), Woodline Partners LP ($99.87K), Blue Owl Capital Holdings LP ($85K), and Renaissance Technologies LLC ($71.73K).

Institutional investors have sold a total of 1,318,771 shares in the last 24 months. This volume of shares sold represents approximately $117.86M in transactions.



Institutional ownership data for NASDAQ:PVLA is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/14/2026. New 13F filings are added each quarter as they're published.
From Our Partners